Cleared Traditional

K921702 - MERI-DAPT(TM) HEMOSTASIS VALVE/TORQLOC TORQUE DEVI

K921702 is an FDA 510(k) clearance for MERI-DAPT(TM) HEMOSTASIS VALVE/TORQLOC ..., manufactured by Merit Medical Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 164-day FDA review.

K921702 · Merit Medical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1992
Decision
164d
Days
Class 2
Risk

K921702 is an FDA 510(k) clearance for the MERI-DAPT(TM) HEMOSTASIS VALVE/TORQLOC TORQUE DEVI. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Merit Medical Systems, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on September 21, 1992 after a review of 164 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Merit Medical Systems, Inc. devices

FDA 510(k) Submission Details - K921702

510(k) Number K921702 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 1992
Decision Date September 21, 1992
Days to Decision 164 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 125d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 681
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K921702.
CORDIS STEERABLE GUIDEWIRE
K923134 · Cordis Corp. · Oct 1992
ROADRUNNER RLTF GUIDE WIRE
K920824 · Cook, Inc. · Oct 1992
BAXTER SENSOR CORONARY GUIDEWIRE
K923240 · Baxter Healthcare Corp · Sep 1992
JAGWIRE(TM) RECANALIZATION GUIDEWIRE
K922302 · Boston Scientific Corp · Jul 1992
SCIMED AVENUE CORONARY GUIDEWIRE INSERTION TOOL
K922410 · Scimed Life Systems, Inc. · Jul 1992
SCIMED(R) CONTROLWIRE(TM) GUIDE WIRE
K914194 · Scimed Life Systems, Inc. · Jun 1992